Home » Authors » Karen Young

Articles by Karen Young

Ligand, Lilly Extend Collaboration In PPARs For Multiple Indications

April 15, 2002

Pozen’s Second Phase III Confirms MT 100 On Par With Market Leader

April 12, 2002

Versicor Raises $44.9M Privately To Advance Lead Compounds

April 12, 2002

Versicor Raises $44.9M Privately To Advance Lead Compounds

April 12, 2002

Pozen’s Second Phase III Confirms MT 100 On Par With Market Leader

April 12, 2002

ISTA Receives FDA Go-Ahead To Submit NDA For Vitrase

April 11, 2002

ISTA Receives FDA Go-Ahead To Submit NDA For Vitrase

April 11, 2002

Hyseq Raises $15M Privately To Develop Proprietary Drugs

April 10, 2002

AEterna Seeks Acquisitions In Cancer Following C$57M Financing

April 10, 2002

AEterna Seeks Acquisitions In Cancer Following C$57M Financing

April 10, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 8, 2025
STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space
BioWorld
Kaken Pharmaceutical Co. Ltd.’s license agreement with Johnson & Johnson (J&J) for signal transducer and activator of transcription (STAT)6 inhibitor KP-723 could...
GLP-1 receptor agonists continue their global victory tour
BioWorld
2024 was another banner year for GLP-1 receptor agonists (GLP-1RAs) on multiple fronts. They continued to expand into new indications, and provide their...
AI drives financings, approvals for APAC med-tech in 2024
BioWorld MedTech
AI pulled in major financings and approvals for Asia med-techs in 2024 as Asia Pacific countries played to individual strengths to maximize AI’s applications in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.